icon_0328_cc_gen_hmr_bacteria-s

Endometrial Cancer Signaling

Endometrial cancers are most commonly identified as adenocarcinomas. They fall into two clinicopathologic subtypes: Type I (endometrioid and mucinous carcinomas) is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age. Type II (serous and clear cell carcinomas) is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age.Molecular/genetic changes differ between Type I and Type II carcinomas. Genetic alterations in Type I carcinomas include mutations to tumor suppressor genes PTEN and p52, microsatellite instability and mutations to oncogenes K-Ras and β-catenin...

Endometrial Cancer Signaling

Pathway Summary

Endometrial cancers are most commonly identified as adenocarcinomas. They fall into two clinicopathologic subtypes: Type I (endometrioid and mucinous carcinomas) is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age. Type II (serous and clear cell carcinomas) is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age.Molecular/genetic changes differ between Type I and Type II carcinomas. Genetic alterations in Type I carcinomas include mutations to tumor suppressor genes PTEN and p52, microsatellite instability and mutations to oncogenes K-Ras and β-catenin. PTEN/K-Ras mutations and microsatellite instability are considered early events, occurring in a subset of atypical endometrial hyperplasias whereas p53 mutation is a later event. Type II carcinomas are most frequently caused by mutations to the p53 gene followed by amplification of the her2/neu gene.

Endometrial Cancer Signaling Genes list

Explore Genes related to Endometrial Cancer Signaling

Products related to Endometrial Cancer Signaling

Explore products related to Endometrial Cancer Signaling
GeneGlobe ID: SBHS-033Z | Cat. No.: 249950 | QuantiNova LNA PCR Focus Panels
QuantiNova LNA PCR Focus Panel Human Cancer PathwayFinder
QuantiNova LNA PCR Focus Panel
Product Specification
Copy Details
GeneGlobe ID: UPHS-033Z | Cat. No.: 249955 | QuantiNova LNA Probe PCR Focus Panels
QuantiNova LNA Probe PCR Focus Panel Human Cancer PathwayFinder
QuantiNova LNA Probe PCR Focus Panel
Product Specification
Copy Details
GeneGlobe ID: JHS-3001Z | Cat. No.: | QIAseq RNA Fusion XP Panels
RNA Fusion XP Oncology Research Panel
Kit containing ALL reagents (except indexes) for fusion and gene expression profiling by digital RNAseq
Product Specification
Copy Details
GeneGlobe ID: PHS-3000Z | Cat. No.: | QIAseq Targeted DNA Pro Panels
QIAseq Targeted DNA Pro Human Comprehensive Cancer Research Panel
Kit containing ALL reagents (except indexes) for targeted DNA sequencing
Product Specification
Copy Details
GeneGlobe ID: JHS-002Z | Cat. No.: | QIAseq RNA Fusion XP Panels
RNA Fusion XP Solid Tumor Panel
Kit containing ALL reagents (except indexes) for fusion and gene expression profiling by digital RNAseq
Product Specification
Copy Details
GeneGlobe ID: PAHS-033Z | Cat. No.: 330231 | RT2 Profiler PCR Arrays
RT² Profiler™ PCR Array Human Cancer PathwayFinder™
RT2 Profiler PCR Array
Product Specification
Copy Details
GeneGlobe ID: PHS-3100Z | Cat. No.: | QIAseq Targeted DNA Pro Panels
QIAseq Targeted DNA Pro Human Comprehensive Cancer Focus Panel
Kit containing ALL reagents (except indexes) for targeted DNA sequencing
Product Specification
Copy Details

Didn't find what you're looking for?

Discover other products relevant to this gene list with our Panel Finder. Check it out.